On 4/4/25, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) stock suffered a major decline of -10.7%, closing at $60.26. Moreover, exceptionally high trading volume at 235% of normal accompanied the decline. Relative to the market the stock […]
Banco Santander SA (NYSE: SAN) stock closed at $5.87 on 4/4/25 after a major decline of -10.7%. Moreover, this decline was accompanied by exceptionally high trading volume at 223% of normal. The stock has been […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened recently. AZN’s current Value Trend Rating is D and the prior Rating was C. Details […]
Ardelyx Inc (NASDAQ: ARDX). Extremely important negative changes in investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume. Ardelyx Inc (NASDAQ: ARDX). Meaningful negative changes in fundamentals […]
Stock Rating Downgrade The Value Trend Rating for AMCON Distributing Co (NYSEAMERICAN: DIT) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
Vale SA (NYSE: VALE) suffers from important negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2025 decreased significantly, and the consensus estimate for December, 2026 decreased significantly. Recent notable […]
VNET Group Inc (NASDAQ: VNET) stock closed at $6.39 on 4/4/25 after a major decline of -12.8%. NORMAL trading volume accompanied the decline. The stock has declined -29.1% during the last week but has been […]
Unum Group (NYSE: UNM) stock suffered a major decline of -10.2% on 4/4/25. The shares closed at $71.17. Moreover, unusually high trading volume at 164% of normal accompanied the decline. The stock has been exceptionally […]
On 4/4/25, Two Harbors Investment Corp (NYSE: TWO) stock suffered a major decline of -10.3%, closing at $11.54. Moreover, exceptionally high trading volume at 235% of normal accompanied the decline. The stock has performed in […]
Stock Rating Upgrade The Value Trend Rating for Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) rose significantly in recent days from C to A reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research